• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Abiraterone Teva 250 mg
    / Teva


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    120 X 250 mg

    partial basket chart 55637

    Related information


    Dosage

    Intended for male patients only. 1,000 mg (four 250mg tablets) once daily in combination with prednisone.


    Indications

    The drug CYP inhibitor and it is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.


    Contra-Indications

    Hypersensitivity to active substance or any of its excipients. Use in female patients. Severe hepatic impairment.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE